Pharmaceutical companies with Alzheimer's drugs in development 2019
As of September 2019, U.S. pharmaceutical company Eli Lilly had six drugs in development for the treatment of Alzheimer's disease in various stages of clinical trials, followed by Biogen with five drugs in development.